32.4 C
Bangkok
Tuesday, May 14, 2024

AstraZeneca Thailand partners with BMA to enhance early-stage lung cancer diagnosis

“AstraZeneca aims to enhance the quality of life and wellness for patients by pushing the boundaries of science to provide more sustainable healthcare for people, society, and the planet,” said Roman Ramos, country president, AstraZeneca (Thailand).

“Oncology is one of the focus areas in our diversified portfolio. Through researching and developing innovative solutions, we use AI to expand the capacity and efficiency of pre-screening, aligned with Thailand’s public health pathway for innovation and towards digital healthcare. As we move ahead, we aspire to redefine healthcare and scale up AI technology utilisation to aid lung cancer pre-screening, with the aim to avail accessibility to 500,000 individuals by 2024 and eventually, increase survival rates for lung cancer patients in Thailand,” Ramos said.

Formed by four founding partners…

Read more…

Latest Articles